TULANE UNIVERSITY HOSPITAL & CLINICS
1. Target Overview & Investment Thesis
TULANE UNIVERSITY HOSPITAL & CLINICS is a 431-bed suburban community hospital in ORLEANS PARISH, LA with $490.2M in net patient revenue and a -14.1% operating margin. The hospital serves a payer mix of 18.2% Medicare, 0.4% Medicaid, and 81.4% commercial.
Thesis: Undervalued. Our ML models identify $36.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.1% to -6.7% (+736bps).
| Net Revenue HCRIS | $490.2M |
| Current EBITDA COMPUTED | $-69.0M |
| Operating Margin COMPUTED | -14.1% |
| Occupancy HCRIS | 54.4% |
| Revenue / Bed COMPUTED | $1.1M |
| Net-to-Gross HCRIS | 10.6% |
| Distress Probability ML | 44.8% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -14.1% places it below the state median. Among 20 size-comparable peers (216-862 beds), the median margin is -6.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (216-862), prioritizing same-state peers. 20 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| TULANE UNIVERSITY HOSPITAL & C (Target) | LA | 431 | $490.2M | -14.1% |
| OUR LADY OF THE LAKE RMC | LA | 647 | $1.31B | -2.8% |
| WILLIS-KNIGHTON HEALTH SYSTEMS | LA | 686 | $1.02B | 6.9% |
| UNIVERSITY MEDICAL CTR. AT NEW | LA | 310 | $671.3M | -22.4% |
| OUR LADY OF LOURDES RMC | LA | 363 | $509.6M | 8.9% |
| LAFAYETTE GENERAL MEDICAL CENT | LA | 390 | $480.2M | -16.4% |
| BATON ROUGE GENERAL | LA | 251 | $445.5M | -6.7% |
| OCHSNER LSU HEALTH SHREVEPORT | LA | 273 | $395.6M | -50.0% |
| TOURO INFIRMARY | LA | 270 | $369.4M | -3.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $36.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $10.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $9.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $9.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $314K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-69.0M |
| + RCM Uplift | +$36.1M |
| Pro Forma EBITDA | $-32.9M |
| Current Margin | -14.1% |
| Pro Forma Margin | -6.7% |
| WC Released (1x) | $18.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-106.1M | $-94.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-106.1M | $-138.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-95.5M | $-53.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-95.5M | $-86.5M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-116.7M | $-240.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-116.7M | $-302.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 20 hospitals with 216-862 beds
- Same-state prioritization (n=21)
- Comp margins: P25=-16.8% / P50=-6.3% / P75=-0.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.